Quetiapinfumarat (Ph.Eur.) shortage — availability across Europe

Key facts

• As of 11 September 2026, Quetiapinfumarat (Ph.Eur.) has active availability issues in 2 of 9 tracked European registers.
• Registers reporting issues: Germany, Greece.
• Latest expected-resolution date on file: 2027-03-31.
• Longest-running open report: since 2024-07-23 (26 months, Germany).
• Data source: 2 official medicines-agency registers, refreshed daily.

As of 11 September 2026, 2 of the 9 tracked registers list current availability issues for Quetiapinfumarat (Ph.Eur.), covering 51 affected product presentations. The longest-running open report was filed in Germany on 2024-07-23 and has now been open for about 26 months. Where agencies state a cause, manufacturing problems lead with 35 of the 49 stated-cause reports, followed by unexpectedly high demand with 10. The furthest expected-resolution date currently on file is 2027-03-31; the earliest is 2026-09-16. Notably, 2 reports have already passed the expected-resolution date without closing — prognoses for this medicine should be read as estimates, not commitments. Momentum is current, not historical: 6 of the open reports were filed within the last 90 days. Registers in Germany, Greece indicate that alternatives or equivalents are available — a pharmacist or doctor can advise on switching. In the WHO ATC classification, Quetiapinfumarat (Ph.Eur.) is coded N05AH04 — a medicine acting on the nervous system — so clinically related products appear under “Related medicines” below.

New register reports per month

Full report history (51 register entries)

Every individual register entry for Quetiapinfumarat (Ph.Eur.) in the tracked sources, newest first — including resolved and discontinued reports.

Frequently asked

Is Quetiapinfumarat (Ph.Eur.) currently in shortage in Europe?

Yes. As of 11 September 2026, availability issues are reported in: Germany, Greece. Availability is national — a shortage in one country does not mean it is short everywhere.

When is the Quetiapinfumarat (Ph.Eur.) shortage expected to end?

Agency prognoses on file range from 2026-09-16 to 2027-03-31. These are manufacturer-reported estimates and frequently move; check the linked register entry for the latest date.

Are there alternatives to Quetiapinfumarat (Ph.Eur.)?

49 of the active register entries indicate alternatives or equivalents (same active substance or an alternative treatment). Do not switch on your own — a pharmacist or prescriber can confirm the right substitute in your country.

Where does this Quetiapinfumarat (Ph.Eur.) availability data come from?

Directly from the official medicines-agency registers that list Quetiapinfumarat (Ph.Eur.): BfArM (Germany), EOF limited-availability list (Greece). Every row on this page links to the underlying official record, and the dataset is refreshed from the primary sources every morning. Cross-language matching groups the same active substance across registers, so national spellings all resolve to this page.

Related medicines (same ATC class)

Embed this tracker

Pharmacies, patient sites and newsrooms are welcome to embed the live status of Quetiapinfumarat (Ph.Eur.) — free, with attribution. Copy this snippet:

<iframe src="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/quetiapinfumarat-ph-eur/embed.html" width="100%" height="150" loading="lazy" style="border:1px solid #e1e0d9;border-radius:12px" title="Quetiapinfumarat (Ph.Eur.) availability in Europe"></iframe>
<p style="font-size:12px">Source: <a href="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/quetiapinfumarat-ph-eur/">Quetiapinfumarat (Ph.Eur.) shortage status — European Medicine Shortage Tracker</a> by MobiDoctor</p>